BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35769484)

  • 1. A TNFR2-Specific TNF Fusion Protein With Improved
    Vargas JG; Wagner J; Shaikh H; Lang I; Medler J; Anany M; Steinfatt T; Mosca JP; Haack S; Dahlhoff J; Büttner-Herold M; Graf C; Viera EA; Einsele H; Wajant H; Beilhack A
    Front Immunol; 2022; 13():888274. PubMed ID: 35769484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells.
    Leclerc M; Naserian S; Pilon C; Thiolat A; Martin GH; Pouchy C; Dominique C; Belkacemi Y; Charlotte F; Maury S; Salomon BL; Cohen JL
    Blood; 2016 Sep; 128(12):1651-9. PubMed ID: 27506541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNFR2 blockade of regulatory T cells unleashes an antitumor immune response after hematopoietic stem-cell transplantation.
    Moatti A; Debesset A; Pilon C; Beldi-Ferchiou A; Leclerc M; Redjoul R; Charlotte F; To NH; Bak A; Belkacemi Y; Salomon BL; Issa F; Michonneau D; Maury S; Cohen JL; Thiolat A
    J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35387779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion.
    Chopra M; Biehl M; Steinfatt T; Brandl A; Kums J; Amich J; Vaeth M; Kuen J; Holtappels R; Podlech J; Mottok A; Kraus S; Jordán-Garrote AL; Bäuerlein CA; Brede C; Ribechini E; Fick A; Seher A; Polz J; Ottmüller KJ; Baker J; Nishikii H; Ritz M; Mattenheimer K; Schwinn S; Winter T; Schäfer V; Krappmann S; Einsele H; Müller TD; Reddehase MJ; Lutz MB; Männel DN; Berberich-Siebelt F; Wajant H; Beilhack A
    J Exp Med; 2016 Aug; 213(9):1881-900. PubMed ID: 27526711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a TNFR2-Selective Agonistic TNF-α Mutant and Its Derivatives as an Optimal Regulatory T Cell Expander.
    Inoue M; Yamashita K; Tsuji Y; Miki M; Amano S; Okumura T; Kuge K; Tone T; Enomoto S; Yoshimine C; Morita Y; Ando D; Kamada H; Mikami N; Tsutsumi Y; Tsunoda SI
    J Immunol; 2021 Apr; 206(8):1740-1751. PubMed ID: 33782090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bivalent structure of a TNFR2-selective and agonistic TNF-α mutein Fc-fusion protein enhances the expansion activity of regulatory T cells.
    Inoue M; Tsuji Y; Ueno R; Miyamoto D; Tanaka K; Moriyasu Y; Shibata S; Okuda M; Ando D; Abe Y; Kamada H; Tsunoda SI
    Sci Rep; 2023 Aug; 13(1):13762. PubMed ID: 37612373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunocytokine consisting of a TNFR2 agonist and TNFR2 scFv enhances the expansion of regulatory T cells through TNFR2 clustering.
    Inoue M; Tsuji Y; Kashiwada A; Yokoyama A; Iwata A; Abe Y; Kamada H; Tsunoda SI
    Biochem Biophys Res Commun; 2024 Feb; 697():149498. PubMed ID: 38262291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents.
    Zou H; Li R; Hu H; Hu Y; Chen X
    Front Immunol; 2018; 9():594. PubMed ID: 29632537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity.
    Atretkhany KN; Mufazalov IA; Dunst J; Kuchmiy A; Gogoleva VS; Andruszewski D; Drutskaya MS; Faustman DL; Schwabenland M; Prinz M; Kruglov AA; Waisman A; Nedospasov SA
    Proc Natl Acad Sci U S A; 2018 Dec; 115(51):13051-13056. PubMed ID: 30498033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNFR2 signaling modulates immunity after allogeneic hematopoietic cell transplantation.
    Mancusi A; Alvarez M; Piccinelli S; Velardi A; Pierini A
    Cytokine Growth Factor Rev; 2019 Jun; 47():54-61. PubMed ID: 31122819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential roles of TNFα-TNFR1 and TNFα-TNFR2 in the differentiation and function of CD4
    Yang S; Xie C; Chen Y; Wang J; Chen X; Lu Z; June RR; Zheng SG
    Cell Death Dis; 2019 Jan; 10(1):27. PubMed ID: 30631042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNFR2 on non-haematopoietic cells is required for Foxp3+ Treg-cell function and disease suppression in EAE.
    Tsakiri N; Papadopoulos D; Denis MC; Mitsikostas DD; Kollias G
    Eur J Immunol; 2012 Feb; 42(2):403-12. PubMed ID: 22105853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of TNF Receptor 2 Improves Synaptic Plasticity and Enhances Amyloid-β Clearance in an Alzheimer's Disease Mouse Model with Humanized TNF Receptor 2.
    Ortí-Casañ N; Wajant H; Kuiperij HB; Hooijsma A; Tromp L; Poortman IL; Tadema N; de Lange JHE; Verbeek MM; De Deyn PP; Naudé PJW; Eisel ULM
    J Alzheimers Dis; 2023; 94(3):977-991. PubMed ID: 37355890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progranulin promotes tumour necrosis factor-induced proliferation of suppressive mouse CD4⁺ Foxp3⁺ regulatory T cells.
    Hu Y; Xiao H; Shi T; Oppenheim JJ; Chen X
    Immunology; 2014 Jun; 142(2):193-201. PubMed ID: 24383743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology.
    Salomon BL; Leclerc M; Tosello J; Ronin E; Piaggio E; Cohen JL
    Front Immunol; 2018; 9():444. PubMed ID: 29593717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of TNF receptor type 2 expands regulatory T cells and ameliorates established collagen-induced arthritis in mice.
    Lamontain V; Schmid T; Weber-Steffens D; Zeller D; Jenei-Lanzl Z; Wajant H; Straub RH; Männel DN
    Cell Mol Immunol; 2019 Jan; 16(1):65-74. PubMed ID: 29375132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superior Treg-Expanding Properties of a Novel Dual-Acting Cytokine Fusion Protein.
    Padutsch T; Sendetski M; Huber C; Peters N; Pfizenmaier K; Bethea JR; Kontermann RE; Fischer R
    Front Pharmacol; 2019; 10():1490. PubMed ID: 31920671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked in Vivo Donor Regulatory T Cell Expansion via Interleukin-2 and TL1A-Ig Stimulation Ameliorates Graft-versus-Host Disease but Preserves Graft-versus-Leukemia in Recipients after Hematopoietic Stem Cell Transplantation.
    Wolf D; Barreras H; Bader CS; Copsel S; Lightbourn CO; Pfeiffer BJ; Altman NH; Podack ER; Komanduri KV; Levy RB
    Biol Blood Marrow Transplant; 2017 May; 23(5):757-766. PubMed ID: 28219835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Significance of Tumor Necrosis Factor Receptor Type II in CD8
    Ye LL; Wei XS; Zhang M; Niu YR; Zhou Q
    Front Immunol; 2018; 9():583. PubMed ID: 29623079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the DR3-TL1A Axis in Donor Mice Leads to Regulatory T Cell Expansion and Activation With Reduction in Graft-Versus-Host Disease.
    Mavers M; Simonetta F; Nishikii H; Ribado JV; Maas-Bauer K; Alvarez M; Hirai T; Turkoz M; Baker J; Negrin RS
    Front Immunol; 2019; 10():1624. PubMed ID: 31379829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.